Spending decisions for tobacco-related disease treatment and tobacco control: an example and a solution.
Thomson
George
G
Wilson
Nick
N
D001993:Bronchodilator Agents / Q000191:economics / Q000627:therapeutic use; D003362:Cost-Benefit Analysis; D005102:Health Expenditures; D006293:Health Promotion / Q000191:economics*; D007356:Insurance, Pharmaceutical Services; D009520:New Zealand; D029424:Pulmonary Disease, Chronic Obstructive / Q000188:drug therapy / Q000191:economics; D012602:Scopolamine Derivatives / Q000191:economics / Q000627:therapeutic use; D012907:Smoking / Q000191:economics; D016540:Smoking Cessation / Q000191:economics*; D000069447:Tiotropium Bromide
D001993:Bronchodilator Agents; D012602:Scopolamine Derivatives; D000069447:Tiotropium Bromide